
ADA 2025: Advances in Type 2 Diabetes Management With Tirzepatide
Insights into the therapeutic profile of tirzepatide (Mounjaro, Zepbound; Eli Lilly and Company), a novel agent for the treatment of type 2 diabetes (T2D), were shared during a presentation at the 85th Scientific Sessions of the American Diabetes …